Navigation Links
ViewRay Secures Series C Financing
Date:8/25/2010

CLEVELAND, Aug. 25 /PRNewswire/ -- ViewRay™, Inc., a privately held medical device company, has secured $20 million in Series C financing led by new investor Siemens Venture Capital (SVC) GmbH and joined by existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors. The funding is intended to move the ViewRay system, a unique image-guided radiation therapy system now in the late stages of development, through the process of commercialization and placement in major medical centers.*

The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of simultaneous magnetic resonance imaging (MRI) and radiotherapy delivery. "MRI-guided radiotherapy has great potential, and we believe ViewRay has the technology and the team to bring it to fruition," said Ralf Schnell, CEO, Siemens Venture Capital.

"We are pleased to welcome SVC to our team, adding to the technology partnership with the Siemens MR business unit of Siemens AG," said Gregory M. Ayers, MD, PhD, ViewRay president and CEO. "The continuing commitment of our present investors is a testament to both the significant progress we have made in development of our system and the overall promise of MRI-guided radiotherapy."

* At this time, the ViewRay system is for nonclinical research use only. The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, will soon become the first in the world to test the ViewRay system.

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is intended to provide continuous soft-tissue imaging during treatment. The system is being designed so that clinicians—for the first time—will be able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. Since 2009, Siemens AG has partnered with ViewRay to develop advanced MRI technology for the ViewRay system. For more information, visit http://www.viewray.com.

About Aisling Capital

Aisling Capital is a dedicated life sciences private equity firm with US$1 billion under management. Headquartered in New York, Aisling Capital invests in both private and public companies, utilizing a wide variety of investment structures. The Aisling Capital team's combination of clinical, operational and financial experience allows the firm to identify, execute and realize investments across the life sciences industry. For more information, visit http://www.aislingcapital.com.

About Fidelity Biosciences

Fidelity Biosciences is a division of Fidelity Investments, one of the world's leading providers of financial services. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firm's own capital since 1969. This provides us with the flexibility and capabilities of traditional venture capital firms while eliminating the additional pressures of fundraising. The result is a clear focus on building long-term value for Fidelity, our management partners, and coinvestors. For more information, visit http://www.fidelitybiosciences.com.

About Kearny Venture Partners

With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entrepreneurs to devise innovative solutions in healthcare has never been greater. Significant unmet needs in healthcare continue to persist, representing large potential market opportunities for safe and effective products. As the molecular basis of disease is increasingly unraveled, new opportunities for intervention emerge. Novel therapies can and will displace incumbent products. For more information, visit http://www.kearnyvp.com.

About OrbiMed Advisors LLC

OrbiMed is the world's largest fully dedicated healthcare investment firm, with over $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds. For more information, visit http://www.orbimed.com.

About Siemens Venture Capital GmbH

Siemens Venture Capital GmbH (SVC), the central venture capital organization within Siemens, invests in early-stage technology companies and established growth companies, focusing on the energy, industry and healthcare sectors. SVC is focused on innovative solutions from which Siemens can profit and plays a key role in Siemens' global innovation network. To date, the company has invested more than EUR 800 million in over 150 companies and 40 venture capital funds. In addition, SVC advises the German Siemens pension funds on their private equity allocation. As part of this relationship, SVC has launched the venture capital fund of funds Siemens Global Innovation Partners I to capitalize on these opportunities.

ViewRay is a trademark of ViewRay, Inc.


'/>"/>
SOURCE ViewRay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System
2. ViewRay Wins NorTech Innovation Award
3. Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
4. Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
5. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
6. ProUroCare Medical Secures $885,000 in Financing
7. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
8. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
9. Logical Therapeutics Secures $16.9M Series C Financing Round
10. Breathe Technologies Secures $23 Million in Series C Financing
11. Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
(Date:9/7/2017)... WARSAW, Ind. , Sept. 7, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Annual Global Healthcare Conference at the Grand Hyatt hotel ... September 11, 2017 at 11:40 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of ... Home” is the creation of published author, John Allred, a passionate leader of ministry ... International, who has traveled and ministered on four continents. , “It is my hope ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... With ... so fun and easy to do. Users can select from up to two layers ... with a click of a mouse all within Final Cut Pro X. ...
(Date:9/21/2017)... ... September 21, 2017 , ... The American Addiction Treatment ... for professionals in the addiction treatment industry entitled: Special Investigations Unit (SIU) ... companies and state and federal governments are increasingly scrutinizing the addiction treatment industry ...
(Date:9/21/2017)... ... ... Bill Howe Plumbing’s mission is to create an employee friendly company, provide ... over 37 years, they have operated with their mission at the foundation and have ... They were chosen as the Best San Diego plumber in 2016, named a Top ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... developing low-cost and highly accurate cancer screening tests, has received two prestigious recognitions ... in cancer survival rates. , Preora has been named a Top ...
Breaking Medicine News(10 mins):